NYSE:USPH U.S. Physical Therapy (USPH) Stock Price, News & Analysis → [BUY ALERT] Our #1 A.I. Stock for March (From Behind the Markets) (Ad) Free USPH Stock Alerts $112.86 +1.89 (+1.70%) (As of 03/28/2024 ET) Add Compare Share Share Today's Range$110.94▼$113.2150-Day Range$92.27▼$110.9052-Week Range$78.08▼$124.11Volume65,902 shsAverage Volume67,669 shsMarket Capitalization$1.70 billionP/E Ratio83.60Dividend Yield1.56%Price Target$125.67 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get U.S. Physical Therapy alerts: Email Address U.S. Physical Therapy MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside11.3% Upside$125.67 Price TargetShort InterestHealthy4.95% of Shares Sold ShortDividend StrengthModerateBased on Four FactorsSustainabilityN/ANews SentimentN/AInsider TradingSelling Shares$1.14 M Sold Last QuarterProj. Earnings Growth10.47%From $2.77 to $3.06 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.33 out of 5 starsMedical Sector480th out of 938 stocksHealth Services Industry4th out of 10 stocks 2.5 Analyst's Opinion Consensus RatingU.S. Physical Therapy has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $125.67, U.S. Physical Therapy has a forecasted upside of 11.3% from its current price of $112.86.Amount of Analyst CoverageU.S. Physical Therapy has only been the subject of 2 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted4.95% of the outstanding shares of U.S. Physical Therapy have been sold short.Short Interest Ratio / Days to CoverU.S. Physical Therapy has a short interest ratio ("days to cover") of 11, which indicates bearish sentiment.Change versus previous monthShort interest in U.S. Physical Therapy has recently decreased by 5.45%, indicating that investor sentiment is improving significantly. Previous Next 2.5 Dividend Strength Dividend YieldU.S. Physical Therapy pays a meaningful dividend of 1.61%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthU.S. Physical Therapy has been increasing its dividend for 5 years.Dividend CoverageThe dividend payout ratio of U.S. Physical Therapy is 130.37%. Payout ratios above 75% are not desirable because they may not be sustainable.Dividend SustainabilityBased on earnings estimates, U.S. Physical Therapy will have a dividend payout ratio of 57.52% next year. This indicates that U.S. Physical Therapy will be able to sustain or increase its dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for USPH. Previous Next 0.0 News and Social Media Coverage Search InterestOnly 1 people have searched for USPH on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat FollowsOnly 55 people have added U.S. Physical Therapy to their MarketBeat watchlist in the last 30 days. This is a decrease of -26% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, U.S. Physical Therapy insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,141,535.00 in company stock.Percentage Held by InsidersOnly 1.80% of the stock of U.S. Physical Therapy is held by insiders. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for U.S. Physical Therapy are expected to grow by 10.47% in the coming year, from $2.77 to $3.06 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of U.S. Physical Therapy is 83.60, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 141.99.Price to Earnings Ratio vs. SectorThe P/E ratio of U.S. Physical Therapy is 83.60, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 220.56.Price to Earnings Growth RatioU.S. Physical Therapy has a PEG Ratio of 5.20. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioU.S. Physical Therapy has a P/B Ratio of 3.54. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Behind the Markets[BUY ALERT] Our #1 A.I. Stock for MarchIt's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.Get the name of the stock here - before it takes off >>> About U.S. Physical Therapy Stock (NYSE:USPH)U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. U.S. Physical Therapy, Inc. was founded in 1990 and is based in Houston, Texas.Read More USPH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart USPH Stock News HeadlinesMarch 15, 2024 | insidertrades.comU.S. Physical Therapy, Inc. (NYSE:USPH) Director Clayton Trier Sells 400 SharesMarch 19, 2024 | americanbankingnews.comU.S. Physical Therapy (NYSE:USPH) Upgraded to Hold by StockNews.comMarch 28, 2024 | Behind the Markets (Ad)[BUY ALERT] Our #1 A.I. Stock for MarchIt's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.March 19, 2024 | yahoo.comPhysical: 100 Season 2 – Underground Episode 1: Contestants Participate In Gruesome Pre-Quest MissionMarch 19, 2024 | msn.comNashville abandons physical ability test to hire more female police officersMarch 16, 2024 | msn.comPhysical therapists in Gainesville practice unique non-invasive approach to treat endometriosisMarch 15, 2024 | benzinga.comChief Financial Officer Of US Physical Therapy Makes $193K SaleMarch 12, 2024 | msn.comUpstate physical therapist goes bald for a causeMarch 28, 2024 | Behind the Markets (Ad)[BUY ALERT] Our #1 A.I. Stock for MarchIt's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.March 11, 2024 | businesswire.comU.S. Physical Therapy Announces Change in Medicare Rate Reduction for the Remainder of 2024March 10, 2024 | finance.yahoo.comUSPH Apr 2024 155.000 callMarch 8, 2024 | businesswire.comU.S. Physical Therapy to Present at the Oppenheimer 34th Annual Healthcare MedTech & Services ConferenceMarch 8, 2024 | msn.comU.S. Physical Therapy goes ex dividend MondayMarch 6, 2024 | benzinga.comUS Physical Therapy's Ex-Dividend Date Is Monday, Here's What You Need To KnowMarch 5, 2024 | finance.yahoo.comU.S. Physical Therapy, Inc. (NYSE:USPH) Q4 2023 Earnings Call TranscriptMarch 3, 2024 | finance.yahoo.comU.S. Physical Therapy's (NYSE:USPH) Dividend Will Be Increased To $0.44March 2, 2024 | seekingalpha.comUS Physical Therapy, Inc. (USPH) Q4 2023 Earnings Call TranscriptMarch 2, 2024 | msn.comU.S. Physical Therapy (USPH) Declares $0.44 DividendMarch 1, 2024 | finance.yahoo.comQ4 2023 US Physical Therapy Inc Earnings CallMarch 1, 2024 | finance.yahoo.comU.S. Physical Therapy Full Year 2023 Earnings: EPS Misses ExpectationsFebruary 28, 2024 | msn.comU.S. Physical Therapy Non-GAAP EPS of $0.59 beats by $0.02, revenue of $154.8M beats by $4.53MFebruary 28, 2024 | finance.yahoo.comUS Physical Therapy Inc (USPH) Posts Mixed Fourth Quarter and Full Year 2023 ResultsFebruary 28, 2024 | businesswire.comU.S. Physical Therapy Reports Fourth Quarter and Full Year 2023 ResultsFebruary 28, 2024 | markets.businessinsider.comUS Physical Therapy is about to announce earnings — here's what Wall Street expectsFebruary 27, 2024 | msn.comU.S. Physical Therapy 2023 Earnings PreviewFebruary 22, 2024 | forbes.comBest Online Respiratory Therapy Programs Of 2024February 22, 2024 | msn.comKids who wear school uniforms get less physical activity, study finds: 'There's a problem'See More Headlines Receive USPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for U.S. Physical Therapy and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/28/2024Ex-Dividend for 4/5 Dividend3/11/2024Today3/28/2024Dividend Payable4/05/2024Next Earnings (Estimated)5/01/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Health services Sub-IndustryHealth Care Facilities Current SymbolNYSE:USPH CUSIP90337L10 CIK885978 Webwww.usph.com Phone(713) 297-7000Fax713-297-7090Employees6,720Year FoundedN/APrice Target and Rating Average Stock Price Target$125.67 High Stock Price Target$138.00 Low Stock Price Target$117.00 Potential Upside/Downside+11.3%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)$1.35 Trailing P/E Ratio83.60 Forward P/E Ratio40.74 P/E Growth5.2Net Income$28.24 million Net Margins4.67% Pretax Margin8.16% Return on Equity8.52% Return on Assets3.92% Debt Debt-to-Equity Ratio0.29 Current Ratio2.28 Quick Ratio2.28 Sales & Book Value Annual Sales$604.80 million Price / Sales2.81 Cash Flow$4.80 per share Price / Cash Flow23.52 Book Value$31.85 per share Price / Book3.54Miscellaneous Outstanding Shares15,070,000Free Float14,797,000Market Cap$1.70 billion OptionableOptionable Beta1.38 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Christopher J. Reading (Age 60)President, CEO & Director Comp: $1.39MMr. Carey P. Hendrickson (Age 62)Chief Financial Officer Comp: $651.95kMr. Richard S. Binstein (Age 63)Executive VP, General Counsel & Secretary Comp: $478.65kMr. Graham D. Reeve M.B.A. (Age 60)P.T., Chief Operating Officer - West Comp: $877.68kMr. Eric Joseph Williams (Age 58)Chief Operating Officer - East Comp: $702.18kMr. Jake Martinez (Age 45)Senior Vice President of Finance & Accounting Mr. Chadd PenceSenior Vice President of Information SystemsMs. Jayne Fleck Pool ATCPT, SCS, Senior VP & Chief Compliance OfficerMr. Jason AndersonVice President of Human ResourcesMr. Jon C. Bates CPA (Age 53)M.B.A., VP & Corporate Controller More ExecutivesKey CompetitorsPrivia Health GroupNASDAQ:PRVALifeStance Health GroupNASDAQ:LFSTTalkspaceNASDAQ:TALKInnovAgeNASDAQ:INNVThe Pennant GroupNASDAQ:PNTGView All CompetitorsInsiders & InstitutionsCarey P HendricksonSold 1,800 sharesTotal: $193,104.00 ($107.28/share)Richard BinsteinSold 2,000 sharesTotal: $213,100.00 ($106.55/share)Clayton TrierSold 400 sharesTotal: $42,800.00 ($107.00/share)Vanguard Group Inc.Bought 26,224 shares on 3/11/2024Ownership: 7.050%Graham D ReeveSold 2,629 sharesTotal: $274,441.31 ($104.39/share)View All Insider TransactionsView All Institutional Transactions USPH Stock Analysis - Frequently Asked Questions Should I buy or sell U.S. Physical Therapy stock right now? 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for U.S. Physical Therapy in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" USPH shares. View USPH analyst ratings or view top-rated stocks. What is U.S. Physical Therapy's stock price target for 2024? 4 Wall Street analysts have issued 1-year target prices for U.S. Physical Therapy's shares. Their USPH share price targets range from $117.00 to $138.00. On average, they expect the company's share price to reach $125.67 in the next twelve months. This suggests a possible upside of 11.3% from the stock's current price. View analysts price targets for USPH or view top-rated stocks among Wall Street analysts. How have USPH shares performed in 2024? U.S. Physical Therapy's stock was trading at $93.14 at the beginning of 2024. Since then, USPH shares have increased by 21.2% and is now trading at $112.86. View the best growth stocks for 2024 here. When is U.S. Physical Therapy's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024. View our USPH earnings forecast. How were U.S. Physical Therapy's earnings last quarter? U.S. Physical Therapy, Inc. (NYSE:USPH) posted its quarterly earnings results on Wednesday, February, 28th. The company reported $0.59 EPS for the quarter, topping analysts' consensus estimates of $0.57 by $0.02. The company had revenue of $154.80 million for the quarter, compared to analyst estimates of $150.24 million. U.S. Physical Therapy had a trailing twelve-month return on equity of 8.52% and a net margin of 4.67%. U.S. Physical Therapy's revenue was up 9.6% on a year-over-year basis. During the same quarter last year, the company earned $0.58 EPS. How often does U.S. Physical Therapy pay dividends? What is the dividend yield for U.S. Physical Therapy? U.S. Physical Therapy announced a quarterly dividend on Tuesday, February 27th. Investors of record on Tuesday, March 12th will be paid a dividend of $0.44 per share on Friday, April 5th. This represents a $1.76 dividend on an annualized basis and a dividend yield of 1.56%. The ex-dividend date is Monday, March 11th. This is a positive change from the stock's previous quarterly dividend of $0.43. Read our dividend analysis for USPH. Is U.S. Physical Therapy a good dividend stock? U.S. Physical Therapy (NYSE:USPH) pays an annual dividend of $1.76 per share and currently has a dividend yield of 1.61%. The company has been increasing its dividend for 5 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio is 130.37%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, USPH will have a dividend payout ratio of 57.52% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for USPH. What ETFs hold U.S. Physical Therapy's stock? ETFs with the largest weight of U.S. Physical Therapy (NYSE:USPH) stock in their portfolio include Small Cap US Equity Select ETF (RNSC), Invesco S&P SmallCap Health Care ETF (PSCH), SPDR S&P Health Care Services ETF (XHS) and Invesco S&P SmallCap High Dividend Low Volatility ETF (XSHD).iShares U.S. Healthcare Providers ETF (IHF). What is Chris Reading's approval rating as U.S. Physical Therapy's CEO? 38 employees have rated U.S. Physical Therapy Chief Executive Officer Chris Reading on Glassdoor.com. Chris Reading has an approval rating of 49% among the company's employees. This puts Chris Reading in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of U.S. Physical Therapy own? Based on aggregate information from My MarketBeat watchlists, some companies that other U.S. Physical Therapy investors own include Pfizer (PFE), NVIDIA (NVDA), AbbVie (ABBV), CVS Health (CVS), Gilead Sciences (GILD), International Business Machines (IBM), Illumina (ILMN), Johnson & Johnson (JNJ), Lowe's Companies (LOW) and Marathon Petroleum (MPC). Who are U.S. Physical Therapy's major shareholders? U.S. Physical Therapy's stock is owned by many different retail and institutional investors. Top institutional investors include Vanguard Group Inc. (7.09%), Vanguard Group Inc. (7.05%), Copeland Capital Management LLC (4.98%), Boston Trust Walden Corp (3.65%), Southernsun Asset Management LLC (3.20%) and Schroder Investment Management Group (2.85%). Insiders that own company stock include Anne Motsenbocker, Carey P Hendrickson, Christopher J Reading, Clayton Trier, Edward L Kuntz, Eric Joseph Williams, Glenn Mcdowell, Graham D Reeve, Graham D Reeve, Harry S Chapman, Harry S Chapman, Kathleen A Gilmartin, Mark J Brookner and Richard Binstein. View institutional ownership trends. How do I buy shares of U.S. Physical Therapy? Shares of USPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:USPH) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryFed launches fourth dollar overhaulStansberry ResearchBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding U.S. Physical Therapy, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.